These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31718104)

  • 1. A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease.
    Campos RK; Preciado-Llanes L; Azar SR; Lopez-Camacho C; Reyes-Sandoval A; Rossi SL
    Pathogens; 2019 Nov; 8(4):. PubMed ID: 31718104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
    Front Immunol; 2020; 11():591885. PubMed ID: 33224148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
    Folegatti PM; Harrison K; Preciado-Llanes L; Lopez FR; Bittaye M; Kim YC; Flaxman A; Bellamy D; Makinson R; Sheridan J; Azar SR; Campos RK; Tilley M; Tran N; Jenkin D; Poulton I; Lawrie A; Roberts R; Berrie E; Rossi SL; Hill A; Ewer KJ; Reyes-Sandoval A
    Nat Commun; 2021 Jul; 12(1):4636. PubMed ID: 34330906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
    Arévalo MT; Huang Y; Jones CA; Ross TM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007316. PubMed ID: 31026260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.
    Partidos CD; Weger J; Brewoo J; Seymour R; Borland EM; Ledermann JP; Powers AM; Weaver SC; Stinchcomb DT; Osorio JE
    Vaccine; 2011 Apr; 29(16):3067-73. PubMed ID: 21300099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.
    Weger-Lucarelli J; Chu H; Aliota MT; Partidos CD; Osorio JE
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2970. PubMed ID: 25058320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.
    López-Camacho C; Kim YC; Blight J; Lazaro Moreli M; Montoya-Diaz E; Huiskonen JT; Kümmerer BM; Reyes-Sandoval A
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30987160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
    Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
    Front Immunol; 2020; 11():304. PubMed ID: 32194557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.
    Zhang YN; Deng CL; Li JQ; Li N; Zhang QY; Ye HQ; Yuan ZM; Zhang B
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
    Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A measles virus-based vaccine induces robust chikungunya virus-specific CD4
    Schmitz KS; Comvalius AD; Nieuwkoop NJ; Geers D; Weiskopf D; Ramsauer K; Sette A; Tschismarov R; de Vries RD; de Swart RL
    Vaccine; 2023 Oct; 41(43):6495-6504. PubMed ID: 37726181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.
    Broeckel RM; Haese N; Ando T; Dmitriev I; Kreklywich CN; Powers J; Denton M; Smith P; Morrison TE; Heise M; DeFilippis V; Messaoudi I; Curiel DT; Streblow DN
    Front Immunol; 2019; 10():2563. PubMed ID: 31736977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
    Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
    Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection.
    Chen H; Min N; Ma L; Mok CK; Chu JJH
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008910. PubMed ID: 33270642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.
    Plante KS; Rossi SL; Bergren NA; Seymour RL; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(9):e0004007. PubMed ID: 26340754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress in Vaccine Development Against Chikungunya Virus.
    Gao S; Song S; Zhang L
    Front Microbiol; 2019; 10():2881. PubMed ID: 31921059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.
    Rossi SL; Comer JE; Wang E; Azar SR; Lawrence WS; Plante JA; Ramsauer K; Schrauf S; Weaver SC
    J Infect Dis; 2019 Jul; 220(5):735-742. PubMed ID: 31053842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
    Partidos CD; Paykel J; Weger J; Borland EM; Powers AM; Seymour R; Weaver SC; Stinchcomb DT; Osorio JE
    Vaccine; 2012 Jun; 30(31):4638-43. PubMed ID: 22583812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
    Langsjoen RM; Haller SL; Roy CJ; Vinet-Oliphant H; Bergren NA; Erasmus JH; Livengood JA; Powell TD; Weaver SC; Rossi SL
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
    Kumar M; Sudeep AB; Arankalle VA
    Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.